1. Academic Validation
  2. pH-Sensitive Metal-Organic Frameworks for the Improved Inhibition of HepG2 Cell via Folate Receptor-Mediated Targeting and Cascaded CDT Effect

pH-Sensitive Metal-Organic Frameworks for the Improved Inhibition of HepG2 Cell via Folate Receptor-Mediated Targeting and Cascaded CDT Effect

  • Adv Healthc Mater. 2025 Nov 21:e04093. doi: 10.1002/adhm.202504093.
Chen Zhang 1 2 3 Xueyu Pu 1 2 3 Guohua Teng 1 2 3 Fuyi Li 4 Hezhao Bai 1 2 3 Kui Lin 5 Yi Wang 5 Jia Hao 6 Jian Yang 1 2 3 Fei Tian 1 2 3
Affiliations

Affiliations

  • 1 National Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine, Tianjin, P. R. China.
  • 2 Haihe Laboratory of Modern Chinese Medicine, Tianjin, P. R. China.
  • 3 State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, P. R. China.
  • 4 South Australian Immunogenomics Cancer Institute, The University of Adelaide, Adelaide, SA, Australia.
  • 5 Analytical Instrumentation Centre, Tianjin University, Tianjin, P. R. China.
  • 6 School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, P. R. China.
Abstract

Metal-organic frameworks (MOFs) have great potential for the development of targeted drug delivery systems (DDSs) to improve the effectiveness of inhibiting HepG2 cells. Herein, inspired by the solvothermal synthesis method and the concept of designable assembly, MOF (UiO-66-NH2) is first doped by Fe-Cu NPs to form Fe-Cu@MOF and further modified with polydopamine (PDA) and folic acid (FA) to obtain Fe-Cu@MOF-PDA-FA for the loading of resveratrol (RES). The Fe-Cu@MOF-PDA-FA has desirable drug loading efficiency and excellent pH-responsive release of RES. In vitro cellular experiments and 3D hepatoma cell microspheres model, the Fe-Cu@MOF-PDA-FA not only showed low cytotoxicity but also post-drug has a good inhibitory effect on HepG2. In addition, Fe-Cu@MOF-PDA-FA could achieve good tumor penetration via FR-mediated endocytosis, while showing good Anticancer cellular activity and the ability to promote Reactive Oxygen Species (ROS) generation. Therefore, RES@Fe-Cu@MOF-PDA-FA has promising applications as pH-responsive DDS in combination with chemodynamic therapy (CDT) for Cancer therapy.

Keywords

chemodynamic therapy; combination therapy; metal–organic framework; pH‐responsive targeted drug delivery; tumor microenvironment (TME).

Figures
Products